[Other antihyperuricemic agents].
It has been reported that hyperuricemia might be responsible for cardiovascular diseases as well as gout and renal injury. Hypertension and hyperlipidemia, which are also responsible for cardiovascular diseases, are often associated with hyperuricemia. Thus, the treatment of hypertension and hyperlipidemia associated with hyperuricemia is also important. Losartan, an antihypertensive agent, and fenofibrate, an antihyperlipidemic agent, are known to have uric acid lowering effects. Both agents are useful for hyperuricemia with associated with hypertension and hyperlipidemia. In this section, we reported the characteristics and usefulness of these two agents in hyperuricemic patients with hypertension and hyperlipidemia.
Ogino
Kazuhide
K
Center for Clinical Residency Program, Tottori University Hospital.
Igawa
Osamu
O
Hisatome
Ichiro
I
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D004359:Drug Therapy, Combination; D011345:Fenofibrate / Q000627:therapeutic use*; D006073:Gout / Q000209:etiology / Q000517:prevention & control; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D019808:Losartan / Q000627:therapeutic use*; D014527:Uric Acid / Q000378:metabolism
D000959:Antihypertensive Agents; D006074:Gout Suppressants; D000960:Hypolipidemic Agents; D014527:Uric Acid; D019808:Losartan; D011345:Fenofibrate